A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01416597|
Recruitment Status : Completed
First Posted : August 15, 2011
Last Update Posted : December 17, 2012
|Condition or disease||Intervention/treatment|
|Study Type :||Observational|
|Actual Enrollment :||1 participants|
|Official Title:||Effect of Influenza Vaccine Against Mismatched Strains: Systematic Review|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||December 2011|
|Actual Study Completion Date :||December 2011|
Unadjuvanted, monovalent, and trivalent vaccines, and vaccines delivered intramuscularly, intradermally, or intranasally, depending on what is found in the included studies.
- Incidence of laboratory-confirmed influenza [Polymerase Chain Reaction (PCR) or viral culture].
- Incidence of laboratory-confirmed influenza through antibody assay (a less sensitive test than PCR or viral culture), alone or combined with PCR, and/or viral culture.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01416597
|Study Director:||GSK Clinical Trials||GlaxoSmithKline|